MRS-1706 is primarily used in scientific research as a selective antagonist for the A2B adenosine receptor. Its application is significant in studying the role of adenosine receptors in various physiological and pathological processes. Researchers utilize MRS-1706 to investigate its effects on inflammation, immune responses, and cardiovascular function. It helps in understanding the mechanisms of adenosine signaling and its potential therapeutic implications in conditions like asthma, cancer, and ischemic diseases. Additionally, MRS-1706 is employed in pharmacological studies to develop targeted therapies that modulate adenosine receptor activity for improved treatment outcomes.